{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T09:06:55Z","timestamp":1758272815889},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,3,24]],"date-time":"2011-03-24T00:00:00Z","timestamp":1300924800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s00296-011-1852-8","type":"journal-article","created":{"date-parts":[[2011,3,23]],"date-time":"2011-03-23T15:38:01Z","timestamp":1300894681000},"page":"1711-1720","source":"Crossref","is-referenced-by-count":25,"title":["Role of matrix metalloproteinase-3 (MMP-3) and magnetic resonance imaging of sacroiliitis in assessing disease activity in ankylosing spondylitis"],"prefix":"10.1007","volume":"32","author":[{"given":"Eiman","family":"Soliman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Labib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"El-tantawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hamimy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Alhadidy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Aldawoudy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,24]]},"reference":[{"issue":"9","key":"1852_CR1","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/ncprheum0591","volume":"3","author":"R Sengupta","year":"2007","unstructured":"Sengupta R, Stone MA (2007) The assessment of ankylosing spondylitis in clinical practice. Nat Clin Pract Rheumatol 3(9):496\u2013503","journal-title":"Nat Clin Pract Rheumatol"},{"key":"1852_CR2","doi-asserted-by":"crossref","unstructured":"Zochling J, van der Heijde D, Burgos-Vargas R, Collantes E, Davis JC Jr, Dijkmans B, Dougados M, G\u00e9her P, Inman RD, Khan MA, Kvien TK, Leirisalo-Repo M, Olivieri I, Pavelka K, Sieper J, Stucki G, Sturrock RD, van der Linden S, Wendling D, B\u00f6hm H, van Royen BJ, Braun J (2006) ASAS\/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 65:442\u2013452. doi: 10.1136\/ard.2005.041137","DOI":"10.1136\/ard.2005.041137"},{"key":"1852_CR3","unstructured":"Garrett S, Jenkinson T, Kennedy G, BASDAI et al (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286\u201391"},{"key":"1852_CR4","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/01.SMJ.0000066946.56322.3C","volume":"97","author":"K Yildirim","year":"2004","unstructured":"Yildirim K, Erdal A, Karatay S et al (2004) Relationship between some acute phase reactants and the Bath ankylosing Spondylitis Disease Activity Index in patients with ankylosing spondylitis. South Med J 97:350\u2013353","journal-title":"South Med J"},{"key":"1852_CR5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.54.1.25","volume":"54","author":"RM Hembry","year":"1995","unstructured":"Hembry RM, Bagga MR, Reynolds JJ et al (1995) Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis. Ann Rheum Dis 54:25\u201332","journal-title":"Ann Rheum Dis"},{"key":"1852_CR6","doi-asserted-by":"crossref","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","volume":"274","author":"H Nagase","year":"1999","unstructured":"Nagase H, Woessner JF Jr (1999) Matrix metalloproteinases. J Biol Chem 274:21491\u201321494","journal-title":"J Biol Chem"},{"key":"1852_CR7","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","volume":"92","author":"R Visse","year":"2003","unstructured":"Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92:827\u2013839","journal-title":"Circ Res"},{"key":"1852_CR8","doi-asserted-by":"crossref","first-page":"17238","DOI":"10.1016\/S0021-9258(17)44894-0","volume":"265","author":"KL MacNaul","year":"1990","unstructured":"MacNaul KL, Chartrain N, Lark M, Tocci MJ et al (1990) Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression. J Biol Chem 265:17238\u201317245","journal-title":"J Biol Chem"},{"key":"1852_CR9","first-page":"151","volume":"378","author":"H Nagase","year":"1997","unstructured":"Nagase H (1997) Activation mechanisms of matrix metalloproteinases. Biol Chem 378:151\u2013160","journal-title":"Biol Chem"},{"key":"1852_CR10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/ard.61.2.161","volume":"61","author":"C Ribbens","year":"2002","unstructured":"Ribbens C, Martin y Porras M, Franchimont N et al (2002) Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment. Ann Rheum Dis 61:161\u2013166","journal-title":"Ann Rheum Dis"},{"key":"1852_CR11","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1002\/art.20477","volume":"50","author":"B Vandooren","year":"2004","unstructured":"Vandooren B, Kruithof E, Yu DT et al (2004) Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy. Arthritis Rheum 50:2942\u20132953","journal-title":"Arthritis Rheum"},{"key":"1852_CR12","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/rheumatology\/kei208","volume":"45","author":"C Chen","year":"2006","unstructured":"Chen C, Lin K, Yu D et al (2006) Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity. Rheumatology 45:414\u2013420","journal-title":"Rheumatology"},{"key":"1852_CR13","unstructured":"Lukas C, Braun J, van der Heijde D et al (2007) Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experiment. J Rheumatol 34:862\u201370"},{"key":"1852_CR14","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.1780370709","volume":"37","author":"J Braun","year":"1994","unstructured":"Braun J, Bollow M, Eggens U, Konig H, Distler A, Sieper J (1994) Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis Rheum 37:1039\u20131045","journal-title":"Arthritis Rheum"},{"key":"1852_CR15","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/ard.2009.111435","volume":"68","author":"AN Bennett","year":"2009","unstructured":"Bennett AN, Marzo-Ortega H, Emery P et al (2009) Diagnosing axial spondyloarthropathy. The new Assessment in SpondyloArthritis International Society criteria: MRI entering centre stage. Ann Rheum Dis 68:765\u2013767","journal-title":"Ann Rheum Dis"},{"key":"1852_CR16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00256-008-0477-9","volume":"37","author":"U Weber","year":"2008","unstructured":"Weber U, Maksymowych WP (2008) How does imaging help the clinician in the evaluation and management of spondyloarthritis? Skeletal Radiol 37:487\u2013490","journal-title":"Skeletal Radiol"},{"key":"1852_CR17","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/art.21790","volume":"54","author":"J Braun","year":"2006","unstructured":"Braun J, Landewe R, Hermann KG, Han J et al (2006) Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: results of a multicenter, randomized, double-blind, placebo controlled magnetic resonance imaging study. Arthritis Rheum 54:1646\u20131652","journal-title":"Arthritis Rheum"},{"key":"1852_CR18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S Linden van der","year":"1984","unstructured":"van der Linden S, Valkenberg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361\u2013368","journal-title":"Arthritis Rheum"},{"key":"1852_CR19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/art.10397","volume":"47","author":"A Tubergan van","year":"2002","unstructured":"van Tubergan A, Debates I, Ryser L et al (2002) Use of a numerical rating scale as an answer modality in ankylosing spondylitis-specific questionnaires. Arthritis Rheum 47:242\u2013248","journal-title":"Arthritis Rheum"},{"key":"1852_CR20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/rheumatology\/35.1.66","volume":"35","author":"SD Jones","year":"1996","unstructured":"Jones SD, Steiner A, Calin A et al (1996) The Bath ankylosing spondylitis patient global score (BAS-G). Br J Rheumatol 35:66\u201371","journal-title":"Br J Rheumatol"},{"key":"1852_CR21","first-page":"2281","volume":"21","author":"A Calin","year":"1994","unstructured":"Calin A, Garrett S, Whitelock H et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281\u20132285","journal-title":"J Rheumatol"},{"key":"1852_CR22","first-page":"1694","volume":"21","author":"T Jenkinson","year":"1994","unstructured":"Jenkinson T, Mallorie P, Whitelock H et al (1994) Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 21:1694\u20131698","journal-title":"J Rheumatol"},{"key":"1852_CR23","doi-asserted-by":"crossref","unstructured":"Dougados M, Hermann K-G, Landew\u00e9 R et al (2009) The Assessment of SpondyloArthritis International Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68:ii1\u2013ii44","DOI":"10.1136\/ard.2008.104018"},{"key":"1852_CR24","first-page":"393","volume":"19","author":"P Docherty","year":"1992","unstructured":"Docherty P, Mitchell MJ, MacMillan L et al (1992) Magnetic resonance imaging in the detection of sacroiliitis. J Rheumatol 19:393\u2013401","journal-title":"J Rheumatol"},{"key":"1852_CR25","first-page":"527","volume-title":"Dacie and Lewis practical haematology","author":"SM Lewis","year":"2001","unstructured":"Lewis SM (2001) Miscellaneous tests. In: Lewis SM, Bum BJ, Bates I (eds) Dacie and Lewis practical haematology, 9th edn. Churchill Livingstone, London, pp 527\u2013531","edition":"9"},{"key":"1852_CR26","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/ard.53.11.768","volume":"53","author":"DJ Taylor","year":"1994","unstructured":"Taylor DJ, Cheung NT, Dawes PT (1994) Increased serum proMMP-3 in inflammatory arthritides: a potential indicator of synovial inflammatory monokine activity. Ann Rheum Dis 53:768\u2013772","journal-title":"Ann Rheum Dis"},{"key":"1852_CR27","first-page":"S133","volume":"23","author":"J Zochling","year":"2005","unstructured":"Zochling J, Braun J (2005) Assessment of ankylosing spondylitis. Clin Exp Rheumatol 23:S133\u2013S141","journal-title":"Clin Exp Rheumatol"},{"key":"1852_CR28","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/rheumatology\/38.9.878","volume":"38","author":"A Calin","year":"1999","unstructured":"Calin A, Nakache JP, Geuguen A et al (1999) Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology 38:878\u2013882","journal-title":"Rheumatology"},{"key":"1852_CR29","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/rheumatology\/keh595","volume":"44","author":"A Spoorenberg","year":"2005","unstructured":"Spoorenberg A, van Tubergen A, Landewe R et al (2005) Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives. Rheumatology 44:789\u2013795","journal-title":"Rheumatology"},{"key":"1852_CR30","first-page":"980","volume":"26","author":"A Spoorenberg","year":"1999","unstructured":"Spoorenberg A, van der Heijde D, de Klerk E, Dougados M et al (1999) Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26:980\u2013984","journal-title":"J Rheumatol"},{"key":"1852_CR31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/rheumatology\/25.2.171","volume":"25","author":"NJ Sheehan","year":"1986","unstructured":"Sheehan NJ, Slavin BM, Donovan MP et al (1986) Lack of correlation between clinical disease activity and erythrocyte sedimentation rate, acute-phase proteins or protease inhibitors in ankylosing spondylitis. Br J Rheumatol 25:171\u2013174","journal-title":"Br J Rheumatol"},{"key":"1852_CR32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jbspin.2006.07.005","volume":"74","author":"S Ozgocmen","year":"2007","unstructured":"Ozgocmen S, Godekmerdan A, Ozkurt-Zengin F (2007) Acute-phase response clinical measures and disease activity in ankylosing spondylitis. Joint Bone Spine 74:249\u2013253","journal-title":"Joint Bone Spine"},{"key":"1852_CR33","unstructured":"Ruof J, Stucki G (1999) Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review. J Rheumatol 26:966e70"},{"key":"1852_CR34","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/art.20696","volume":"51","author":"Y Chunhua","year":"2004","unstructured":"Chunhua Y, Gu J, Rihl M et al (2004) Serum levels of matrix metalloproteinase 3 and macrophage colony-stimulating factor 1 correlate with disease activity in ankylosing spondylitis. Arthritis Rheum 51:691\u2013699","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1852_CR35","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jbspin.2008.01.026","volume":"75","author":"D Wendling","year":"2008","unstructured":"Wendling D, Cedoz J, Racadot E (2008) Serum levels of MMP-3 and cathepsin K in patients with ankylosing spondylitis: effect of TNFa antagonist therapy. Joint Bone Spine 75(5):559\u2013562","journal-title":"Joint Bone Spine"},{"key":"1852_CR36","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/rheumatology\/keh008","volume":"43","author":"K Puhakka","year":"2004","unstructured":"Puhakka K, Jurik A, Schiottz-Christensenl B et al (2004) Magnetic resonance imaging of sacroiliitis in early seronegative spondylarthropathy. Abnormalities correlated to clinical and laboratory findings. Rheumatology 43:234\u2013237","journal-title":"Rheumatology"},{"key":"1852_CR37","first-page":"1753","volume":"34","author":"J Woo","year":"2007","unstructured":"Woo J, Lee H, Sung I et al (2007) Changes of clinical response and bone biochemical markers in patients with ankylosing spondylitis taking etanercept. Rheumatology 34:1753\u20131759","journal-title":"Rheumatology"},{"issue":"4","key":"1852_CR38","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10067-007-0726-7","volume":"27","author":"L Goh","year":"2008","unstructured":"Goh L, Suresh P, Gafoor A, Hughes P, Hickling P (2008) Disease activity in longstanding ankylosing spondylitis: a correlation of clinical and magnetic resonance imaging findings. Clin Rheumatol 27(4):449\u2013455","journal-title":"Clin Rheumatol"},{"key":"1852_CR39","doi-asserted-by":"crossref","unstructured":"Visvanathan S, Wagner C, Marini JC et al (2007) Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab. Ann Rheum Dis 67:511\u2013517. doi: 10.1136\/ard.2007.071605","DOI":"10.1136\/ard.2007.071605"},{"key":"1852_CR40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.mri.2003.09.002","volume":"22","author":"W Jee","year":"2004","unstructured":"Jee W, McCauley T, Lee S et al (2004) Sacroiliitis in patients with ankylosing spondylitis: association of MR findings with disease activity. Magn Reson Imaging 22:245\u2013250","journal-title":"Magn Reson Imaging"},{"key":"1852_CR41","doi-asserted-by":"crossref","unstructured":"Jarrett SJ, Sivera F, Cawkwell LS, Marzo-Ortega H, McGonagle D, Hensor E, Coates L, O\u2019Connor PJ, Fraser A, Conaghan PG, Emery P (2009) MRI and clinical findings in patients with ankylosing spondylitis eligible for anti-tumour necrosis factor therapy after a short course of etoricoxib. Ann Rheum Dis 68:1466\u20131469. doi: 10.1136\/ard.2008.092213","DOI":"10.1136\/ard.2008.092213"},{"key":"1852_CR42","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2214\/AJR.05.1423","volume":"187","author":"MA Bredella","year":"2006","unstructured":"Bredella MA, Steinbach LS, Morgan S, Ward M, Davis JC (2006) MRI of the sacroiliac joints in patients with moderate to severe ankylosing spondylitis. AJR 187:1420\u20131426","journal-title":"AJR"},{"key":"1852_CR43","doi-asserted-by":"crossref","unstructured":"Song H, Rudwaleit M, Listing J et al (2009) Comparison of the BASDAI and the modified BASDAI (mini-BASDAI) in assessing disease activity in patients with ankylosing spondylitis without peripheral manifestations. Ann Rheum Dis. 68(11):1701\u20131707. doi: 10.1136\/ard.2008.099226","DOI":"10.1136\/ard.2008.099226"},{"key":"1852_CR44","doi-asserted-by":"crossref","unstructured":"Lukas C, Landew\u00e9 R, Sieper J et al (2009) Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 68:18\u201324. doi: 10.1136\/ard.2008.094870","DOI":"10.1136\/ard.2008.094870"},{"key":"1852_CR45","doi-asserted-by":"crossref","unstructured":"van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J, Braun J, Landew\u00e9 R, for the Assessment of SpondyloArthritis international Society (ASAS) (2009) ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68:1811\u20131818. doi: 10.1136\/ard.2008.100826","DOI":"10.1136\/ard.2008.100826"},{"key":"1852_CR46","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1136\/ard.2007.073098","volume":"67","author":"M Rudwaleit","year":"2008","unstructured":"Rudwaleit M, Schwarzlose S, Hilgert ES et al (2008) MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis. Ann Rheum Dis 67:1276\u20131281","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1852_CR47","first-page":"563","volume":"49","author":"P Lord","year":"2010","unstructured":"Lord P, Farragher T, Lunt M et al (2010) Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology. Biol Register Rheumatol 49(3):563\u2013570","journal-title":"Biol Register Rheumatol"},{"key":"1852_CR48","first-page":"2030","volume":"35","author":"W Maksymowych","year":"2008","unstructured":"Maksymowych W, Rahman P, Shojania K et al (2008) Beneficial effects of adalimumab on biomarkers reflecting structural damage in patients with ankylosing spondylitis. Rheumatology 35:2030\u20132037","journal-title":"Rheumatology"},{"key":"1852_CR49","first-page":"1911","volume":"32","author":"W Maksymowych","year":"2005","unstructured":"Maksymowych W, Poole A, Hiebert L et al (2005) Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis. J Rheumatol 32:1911\u20131917","journal-title":"J Rheumatol"},{"key":"1852_CR50","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1002\/art.22589","volume":"56","author":"WP Maksymowych","year":"2007","unstructured":"Maksymowych WP, Landew\u00e9 R, Conner-Spady B et al (2007) Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis. Arthritis Rheum 56:1846\u20131853","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-1852-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-011-1852-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-1852-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T16:20:46Z","timestamp":1637425246000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-011-1852-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,24]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["1852"],"URL":"https:\/\/doi.org\/10.1007\/s00296-011-1852-8","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,24]]}}}